Cargando…
Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Proton Pump Inhibitors
Subacute cutaneous lupus erythematosus (SCLE) is an autoimmune disease that may be induced by proton pump inhibitors (PPIs) in at-risk populations. The US FDA does not recognize SCLE as an adverse event associated with PPIs. We queried the FDA Adverse Event Reporting System database, which contains...
Autor principal: | Aggarwal, Nitish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914530/ https://www.ncbi.nlm.nih.gov/pubmed/27398293 http://dx.doi.org/10.1007/s40801-016-0067-4 |
Ejemplares similares
-
Proton pump inhibitor-induced subacute cutaneous lupus erythematosus
por: Sandholdt, LH, et al.
Publicado: (2014) -
Subacute cutaneous lupus erythematosus due to proton pump inhibitor intake: case report and literature review
por: Reich, Adam, et al.
Publicado: (2012) -
Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: A Case Series of 7 Patients and Brief Review of Literature
por: Kaur, Sukhjot, et al.
Publicado: (2022) -
Capecitabine-induced Subacute Cutaneous Lupus Erythematosus()()
por: Rocha, Aroni, et al.
Publicado: (2019) -
Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
por: Tarazi, Meera, et al.
Publicado: (2018)